207 related articles for article (PubMed ID: 21686135)
21. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
22. Aggregated low density lipoprotein induces tissue factor by inhibiting sphingomyelinase activity in human vascular smooth muscle cells.
Camino-López S; Badimon L; González A; Canals D; Peña E; Llorente-Cortés V
J Thromb Haemost; 2009 Dec; 7(12):2137-46. PubMed ID: 19817993
[TBL] [Abstract][Full Text] [Related]
23. Sphingomyelin metabolism in rat liver after chronic dietary replacement of choline by N-aminodeanol.
Nikolova-Karakashian MN; Russell RW; Booth RA; Jenden DJ; Merrill AH
J Lipid Res; 1997 Sep; 38(9):1764-70. PubMed ID: 9323586
[TBL] [Abstract][Full Text] [Related]
24. Acid sphingomyelinase promotes SGK1-dependent vascular calcification.
Luong TTD; Tuffaha R; Schuchardt M; Moser B; Schelski N; Boehme B; Gollmann-Tepeköylü C; Schramm C; Holfeld J; Pieske B; Gulbins E; Tölle M; van der Giet M; Lang F; Eckardt KU; Voelkl J; Alesutan I
Clin Sci (Lond); 2021 Feb; 135(3):515-534. PubMed ID: 33479769
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
26. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
27. In vitro effects of fat, FA, and cholesterol on sphingomyelin hydrolysis induced by rat intestinal alkaline sphingomyelinase.
Liu JJ; Nilsson A; Duan RD
Lipids; 2002 May; 37(5):469-74. PubMed ID: 12056588
[TBL] [Abstract][Full Text] [Related]
28. Generating ceramide from sphingomyelin by alkaline sphingomyelinase in the gut enhances sphingomyelin-induced inhibition of cholesterol uptake in Caco-2 cells.
Feng D; Ohlsson L; Ling W; Nilsson A; Duan RD
Dig Dis Sci; 2010 Dec; 55(12):3377-83. PubMed ID: 20393874
[TBL] [Abstract][Full Text] [Related]
29. Effects of neutral sphingomyelinase on phenylephrine-induced vasoconstriction and Ca(2+) mobilization in rat aortic smooth muscle.
Zheng T; Li W; Wang J; Altura BT; Altura BM
Eur J Pharmacol; 2000 Mar; 391(1-2):127-35. PubMed ID: 10720644
[TBL] [Abstract][Full Text] [Related]
30. Long- and short-term effects of thyroxine on sphingolipid metabolism in rat liver.
Babenko NA
Med Sci Monit; 2005 May; 11(5):BR131-138. PubMed ID: 15874883
[TBL] [Abstract][Full Text] [Related]
31. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes.
Pahan K; Sheikh FG; Khan M; Namboodiri AM; Singh I
J Biol Chem; 1998 Jan; 273(5):2591-600. PubMed ID: 9446561
[TBL] [Abstract][Full Text] [Related]
32. Effect of tricyclodecan-9-yl potassium xanthate (D609) on phospholipid metabolism and cell death during oxygen-glucose deprivation in PC12 cells.
Larsen EC; Hatcher JF; Adibhatla RM
Neuroscience; 2007 May; 146(3):946-61. PubMed ID: 17434680
[TBL] [Abstract][Full Text] [Related]
33. Hexachlorobenzene-induced alterations on neutral and acidic sphingomyelinases and serine palmitoyltransferase activities. A time course study in two strains of rats.
Billi de Catabbi SC; Setton-Advruj CP; Sterin-Speziale N; San Martín de Viale LC; Cochón AC
Toxicology; 2000 Aug; 149(2-3):89-100. PubMed ID: 10967406
[TBL] [Abstract][Full Text] [Related]
34. Cardiomyocyte specific deficiency of serine palmitoyltransferase subunit 2 reduces ceramide but leads to cardiac dysfunction.
Lee SY; Kim JR; Hu Y; Khan R; Kim SJ; Bharadwaj KG; Davidson MM; Choi CS; Shin KO; Lee YM; Park WJ; Park IS; Jiang XC; Goldberg IJ; Park TS
J Biol Chem; 2012 May; 287(22):18429-39. PubMed ID: 22493506
[TBL] [Abstract][Full Text] [Related]
35. Bcl-xL interrupts oxidative activation of neutral sphingomyelinase.
Okamoto Y; Obeid LM; Hannun YA
FEBS Lett; 2002 Oct; 530(1-3):104-8. PubMed ID: 12387875
[TBL] [Abstract][Full Text] [Related]
36. De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation.
Panjarian S; Kozhaya L; Arayssi S; Yehia M; Bielawski J; Bielawska A; Usta J; Hannun YA; Obeid LM; Dbaibo GS
Prostaglandins Other Lipid Mediat; 2008 Jun; 86(1-4):41-8. PubMed ID: 18400537
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids and cellular cholesterol homeostasis. Effect of ceramide on cholesterol trafficking and HMG CoA reductase activity.
Subbaiah PV; Sowa JM; Singh DK
Arch Biochem Biophys; 2008 Jun; 474(1):32-8. PubMed ID: 18395507
[TBL] [Abstract][Full Text] [Related]
38. Sphingomyelinase D, a novel probe for cellular sphingomyelin: effects on cholesterol homeostasis in human skin fibroblasts.
Subbaiah PV; Billington SJ; Jost BH; Songer JG; Lange Y
J Lipid Res; 2003 Aug; 44(8):1574-80. PubMed ID: 12777467
[TBL] [Abstract][Full Text] [Related]
39. Palmitoyl-ceramide accumulation with necrotic cell death in A549 cells, followed by a steep increase in sphinganine content.
Yamane M
Biochim Open; 2015; 1():11-27. PubMed ID: 29632826
[TBL] [Abstract][Full Text] [Related]
40. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein.
Augé N; Escargueil-Blanc I; Lajoie-Mazenc I; Suc I; Andrieu-Abadie N; Pieraggi MT; Chatelut M; Thiers JC; Jaffrézou JP; Laurent G; Levade T; Nègre-Salvayre A; Salvayre R
J Biol Chem; 1998 May; 273(21):12893-900. PubMed ID: 9582320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
